Lauren Sabella

COO at Acorda Therapeutics


Lauren Sabella has been Chief Operations Officer at Acorda since September 2021, with responsibility for Strategic Planning, Business Operations, Technical Operations, Information Technology, and Quality. Ms. Sabella joined Acorda in 2010 as Executive Vice President of Commercial Development, with responsibility for the commercial launch of Ampyra, and became Chief Commercial Officer at Acorda in February 2015.

Before joining Acorda, Ms. Sabella was the Founder and Principal of Tugboat Consulting Group, an independent consulting practice assisting companies in the commercialization process. Ms. Sabella also served as Corporate Officer and Vice President of Commercial Development at Altus Pharmaceuticals, with responsibility for all aspects of commercialization. Prior to joining Altus, Ms. Sabella was employed by Boehringer Ingelheim Pharmaceuticals for 18 years in positions of increasing responsibility. In her last role, she served as Vice President of Sales, Eastern Zone, where she led the successful sales launch of Spiriva® (tiotropium bromide) and ran both Primary Care and Specialty Divisions, including Neurology, Urology, and Cardio/Pulmonary. Prior to this role, she had over ten years of marketing experience where she led several product launches including Mobic® (meloxicam), an NSAID which became a $1 billion brand. Ms. Sabella holds a B.B.A. from Hofstra University.


  • COO

    Current role

  • Chief Commercial Officer

View in org chart

The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.